Clarus Therapeutics Holdings Inc
CRXT
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $24.31 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.35 |
| Beta | 0 |
| Outstanding Shares | 9,153,848 |
Return
| Return on Equity | 448.76% |
|---|---|
| Return on Assets | -119.78% |
| Return on Invested Capital | 256.98% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.02 |
| Price to Book Ratio | -0.02 |
| Enterprise Value to Revenue | 1.26 |
| Enterprise Value to EBIT | -0.74 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.79 |
| Debt to Equity | -3.33 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Clarus Therapeutics Holdings Inc
2 employees